MIR29B1, microRNA 29b-1, 407024

N. diseases: 212; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.030 Biomarker group BEFREE LX‑2 cells were treated with various concentrations of AST (10, 20 and 40 µM) for 24 or 48 h. miR‑29b was selected based on existing literature, and its targeting gene B cell lymphoma (Bcl)‑2 was predicted by TargetScan and miRanda databases for further analysis. 30896849 2019
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.030 AlteredExpression group BEFREE Analysis of a small subset of B-NHLs belonging to the same histological subtype (Nodal Marginal Zone Lymphoma) highlighted three miRs associated with HCV infection (miR-223, miR-29a and miR-29b) and confirmed decreased level of miR-92a in HBV-/HCV- samples also when considering this restricted B-NHL group. 25236768 2014
CUI: C0079731
Disease: B-Cell Lymphomas
B-Cell Lymphomas
0.030 Biomarker group BEFREE The ability of LMP1 to negatively regulate TCL1 through miR-29b might underlie its B-cell lymphoma growth antagonistic property. 19966860 2010